effect on other faculties, such as cognitive health and frailty for a lot of elderly people.” By using AI software to predict conditions like myopia progression or screening for diabetic retinopathy while developing biopharmaceuticals and cellbased therapies to replace traditional procedures, the institution is improving its capacity for individualised care – targeting diseases at the earliest, most treatable stages. To help realise this goal, Jod is leading the team at SERI to build a strong translational ecosystem.“ We’ re working to maintain and also develop the ecosystem within SERI to support not only the clinician researchers, but also the scientists,” Jod says.
“ That gets more challenging every year, but it’ s vital to have that chain developed for our researchers to produce the high quality publications that we want from academia, while also working with the Translational Development and Commercialisation team( TD & C) to translate those outcomes from academic publications and citations into clinical practice.” Having this ecosystem in place is crucial for SERI’ s work to have a real impact on the people it serves.“ We’ re producing a lot of academic papers.” Jod continues.“ But without the translational work, our patients would never see the benefits of our research.” seri. com. sg
13